alexa Selective Inhibition Of Matrix Metalloprotease-3 And Hyaluronidase By Hyaluronic Acid Alkylamide Derivatives For The Intra-articular Treatment Of Osteoarthritis
ISSN: 2161-1149

Rheumatology: Current Research
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

8th International Conference of Orthopedic Surgeons and Rheumatology
March 22-23, 2017 Rome, Italy

Cristian Guarise
Fidia Farmaceutici Spa, Italy
ScientificTracks Abstracts: Rheumatology
DOI: 10.4172/2161-1149.C1.015
Abstract
Osteoarthritis (OA) is a disease resulting in most cases in the degeneration of articular cartilage. The process of OA development involves inflammation in the early stage of the disease and many mediators, which regulate the expression of several inflammatory proteins and induce the activation of cartilage-degrading enzymes. While the pathway that results in cartilage breakdown is still unclear, there is strong evidence that hyaluronidases (specifically Hyal-2) and metalloproteases (e.g., MMP13 and MMP3) are relevant for the degradation of the ECM. In this study, hyaluronic acid (HA) alkylamides (HYADDs) were selected as the strongest MMP and hyaluronidase inhibitors among a number of glycosaminoglycans which are currently used as viscosupplements, including natural and chemically cross-linked HAs. The role of the alkyl moiety was investigated using HA derivatives with varying alkyl chain lengths and degrees of modification. In vitro and ex vivo studies in synovial fluid from OA patients confirmed the marked inhibition potency of HYADD4 on hyaluronidase (100-fold higher compared to fully sulfate HA). HYADD4 was then screened against 10 different human MMPs in vitro, and the results were validated ex vivo in human synovial fluid (SF). HYADD4 showed the highest inhibition potency against MMP13 and MMP3 (competitive inhibition with Ki in the μmolar range), and no activity against ADAMTS4, elastase and GAPDH (control). Molecular modeling and molecular dynamics studies suggested that HYADD4 may behave as a competitive inhibitor vs. MMP3 (Figure 1A) because of its ability to interact with collagen-binding groove and to participate in the coordination of the catalytic zinc ion. Moreover, C16 alkyl chain may bind effectively to S1’ additional pocket, increasing the affinity of HYADD4. A pilot clinical trial focusing on the inhibition of SF MMP3 by Hymovis® (HYADD4) in OA patients is ongoing in order to confirm the in vitro and in silico results.
Biography

Cristian Guarise is a Senior Researcher at Fidia Farmaceutici Spa, Italy. His main activity includes “Multi-step synthesis of modified natural polymers for application in the field of Osteoarthritis, Wound Healing, Ophthalmic Surgery and Aesthetic Medicine. From 2008-2011, he was a QC Analytical Chemist at Fidia Farmaceutici Spa, Italy. He completed his Master’s degree in Pharma-Biotechnology in 2004 at University of Padua and PhD in Molecular Chemistry at the same university in 2008. His research project entitled “Rapid synthesis and screening of hetero-functionalized catalysts”.

Email: [email protected]

image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords